Abilify and Gambling – Abilify Gambling Lawsuit Consolidated
Filed in: Abilify
References
FDA Drug Safety Communication: FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada). (2016, May 3). Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm498662.htm
Leland v. Bristol-Myers Squibb Company et al. (2016, January 20). Retrieved from https://dockets.justia.com/docket/missouri/mowdce/6:2016cv03023/125659
Moore, T. J. (2014, December 01). Impulse Control Disorders and Dopamine Agonists. Retrieved from http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1916909
Ogbru, O. (2015, April 13). Aripiprazole, Abilify: Drug Facts, Side Effects and Dosing. Retrieved from http://www.medicinenet.com/aripiprazole/article.htm
Sieniuc, K. (2016, October 4). JPML Consolidates Abilify Gambling Suits In Florida - Law360. Retrieved from http://www.law360.com/articles/848183/jpml-consolidates-abilify-gambling-suits-in-florida